| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Acne Vulgaris | D000152 | 35 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Total
4
13-cis-retinoic acid,Isotretinoin
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
Cross Reference
Introduction
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 13-cis-retinoic acid,Isotretinoin?
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
PubChem Associated disorders and diseases
What pathways are associated with 13-cis-retinoic acid,Isotretinoin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
What genes are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 13-cis-retinoic acid,Isotretinoin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mutizwa MM and Sheinbein DM | Are we underdosing acne patients with generic isotretinoin? | 2013 | Dermatol. Online J. | pmid:23374954 |
| Raza K et al. | Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. | 2013 | Colloids Surf B Biointerfaces | pmid:23357735 |
| Raza K et al. | Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation. | 2013 | J Drug Target | pmid:23336181 |
| Bettoli V et al. | Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how. | 2013 | J Dermatolog Treat | pmid:23148804 |
| Alzoubi KH et al. | The effect of genetic polymorphisms of RARA gene on the adverse effects profile of isotretinoin-treated acne patients. | 2013 | Int J Clin Pharmacol Ther | pmid:23782583 |
| Segaran A et al. | Pyoderma gangrenosum arising in a breast reduction scar: seven years post-procedure. | 2013 | J Plast Reconstr Aesthet Surg | pmid:23759719 |
| Huoh KC and Chang KW | Lip abscess associated with isotretinoin treatment of acne vulgaris. | 2013 | JAMA Dermatol | pmid:23760516 |
| Boyraz N and Mustak PK | Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris. | 2013 | Int. J. Dermatol. | pmid:23675954 |
| Crijns I et al. | Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study. | 2013 | Expert Opin Drug Saf | pmid:23163396 |
| Pinheiro SP et al. | Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States. | 2013 | Pharmacoepidemiol Drug Saf | pmid:23913625 |
| Fain K and Alexander GC | Are Food and Drug Administration prescription drug safety plans working? A case study of isotretinoin. | 2013 | Pharmacoepidemiol Drug Saf | pmid:24115318 |
| Prevost N and English JC | Isotretinoin: update on controversial issues. | 2013 | J Pediatr Adolesc Gynecol | pmid:24147278 |
| In Brief: Absorica for acne. | 2013 | Med Lett Drugs Ther | pmid:24892143 | |
| Webster GF et al. | Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study. | 2013 | J. Am. Acad. Dermatol. | pmid:23953888 |
| Ustun I et al. | Gynecomastia: a rare complication of isoretinoin? | 2013 | Cutan Ocul Toxicol | pmid:22813063 |
| Morales-Cardona CA and Sánchez-Vanegas G | Acne relapse rate and predictors of relapse following treatment with oral isotretinoin. | 2013 | Actas Dermosifiliogr | pmid:22795452 |
| Soriano EA et al. | Cardiac remodeling induced by 13-cis retinoic acid treatment in acne patients. | 2013 | Int. J. Cardiol. | pmid:21663986 |
| D'Erme AM et al. | Association between isotretinoin and mood changes: myth or reality? An updated overview. | 2013 | Int. J. Dermatol. | pmid:21913911 |
| Etminan M et al. | Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. | 2013 | JAMA Dermatol | pmid:23426479 |
| Popescu CM and Bigby M | The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease. | 2013 | JAMA Dermatol | pmid:23426480 |
| Nya-Ngatchou JJ et al. | Intratesticular 13-cis retinoic acid is lower in men with abnormal semen analyses: a pilot study. | 2013 | Andrology | pmid:23413144 |
| Park HC et al. | Treatment of multiple eccrine hidrocystomas with isotretinoin followed by carbon dioxide laser. | 2013 | J. Dermatol. | pmid:23414089 |
| Aktürk AŞ et al. | Effects of isotretinoin on serum vitamin E levels in patients with acne. | 2013 | Int. J. Dermatol. | pmid:23414163 |
| Stuart SA et al. | A translational rodent assay of affective biases in depression and antidepressant therapy. | 2013 | Neuropsychopharmacology | pmid:23503126 |
| Snyder R and Thekkumkara T | Interplay between EGR1 and SP1 is critical for 13-cis retinoic acid-mediated transcriptional repression of angiotensin type 1A receptor. | 2013 | J. Mol. Endocrinol. | pmid:23475749 |
| Alonso-de-Celada RM and de-Lucas Laguna R | Safe and successful treatment of acne vulgaris with isotretinoin in a patient with chronic granulomatous disease. | 2012 Sep-Oct | Pediatr Dermatol | pmid:21966949 |
| Ramió Montero E et al. | [Isotretinoin associated with risk of suicide]. | 2012 Sep-Oct | Farm Hosp | pmid:22266200 |
| Bansal M et al. | Basal cell nevus syndrome: a rare entity. | 2012 Sep-Oct | Indian J Dermatol Venereol Leprol | pmid:22960843 |
| Sarifakioglu E et al. | Terminal hematuria associated with oral isotretinoin treatment in a patient with acne vulgaris. | 2012 Sep-Oct | Pediatr Dermatol | pmid:22067016 |
| Konjevic G et al. | In vitro increased natural killer cell activity of metastatic melanoma patients with interferon-α alone as opposed to its combination with 13-cis retinoic acid is associated with modulation of NKG2D and CD161 activating receptor expression. | 2012 Oct-Dec | J BUON | pmid:23335538 |
| Rallis E and Korfitis C | Isotretinoin for the treatment of granulomatous rosacea: case report and review of the literature. | 2012 Nov-Dec | J Cutan Med Surg | pmid:23149202 |
| D'Erme AM et al. | Treatment of refractory subacute cutaneous lupus erythematosus with oral isotretinoin: a valid therapeutic option. | 2012 May-Jun | Dermatol Ther | pmid:22913448 |
| Vieira AS et al. | The effect of isotretinoin on triglycerides and liver aminotransferases. | 2012 May-Jun | An Bras Dermatol | pmid:22714752 |
| Pachajoa H and Ordoñez A | [Isotretinoin embryopathy with microtia-anotia and congenital heart disease: case report]. | 2012 May-Jun | Arch Argent Pediatr | pmid:22760759 |
| Goyal T et al. | Familial atrophia maculosa varioliformis cutis: first case report from the Indian subcontinent with pedigree analysis. | 2012 Mar-Apr | Indian J Dermatol Venereol Leprol | pmid:22421651 |
| Larson DL et al. | Does systemic isotretinoin inhibit healing in a porcine wound model? | 2012 | Aesthet Surg J | pmid:23110930 |
| Yook JH et al. | Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin. | 2012 | Clin Toxicol (Phila) | pmid:23116253 |
| Levinson M et al. | Sacroiliitis secondary to isotretinoin. | 2012 | Australas. J. Dermatol. | pmid:23157782 |
| Javanbakht AM et al. | Effects of oral isotretinoin on serum folic acid levels. | 2012 | J Drugs Dermatol | pmid:23135667 |
| Requena C et al. | Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin. | 2012 | Cutis | pmid:22988651 |
| Gardner CR et al. | Synthesis of retinoid enhancers based on 2-aminobenzothiazoles for anti-cancer therapy. | 2012 | Bioorg. Med. Chem. | pmid:23088909 |
| Wang QF et al. | [The preparation and kinetic study on enzymatically-controlled drug release of isotretinoin/amylose inclusion complex]. | 2012 | Yao Xue Xue Bao | pmid:23227555 |
| Thiboutot D et al. | Oral isotretinoin and pregnancy prevention programmes. | 2012 | Br. J. Dermatol. | pmid:21985025 |
| Uslu M et al. | Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements. | 2012 | Acta Derm. Venereol. | pmid:21952746 |
| Gerber PA et al. | Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients. | 2012 | Eur. J. Med. Res. | pmid:22472354 |
| Neudorfer M et al. | Ocular adverse effects of systemic treatment with isotretinoin. | 2012 | Arch Dermatol | pmid:22508771 |
| Cumurcu T et al. | Changes in anterior chamber parameters with the Pentacam rotating Scheimpflug and axial length measurements by ultrasound in patients who use isotretinoin. | 2012 | Curr. Eye Res. | pmid:22510008 |
| Dispenza MC et al. | Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. | 2012 | J. Invest. Dermatol. | pmid:22513780 |
| Bettoni CC et al. | Isotretinoin-loaded nanocapsules: stability and cutaneous penetration by tape stripping in human and pig skin. | 2012 | J Biomed Nanotechnol | pmid:22515077 |
| Karadag AS et al. | Does isotretinoin therapy have any effects on electrocardiography, heart rate and blood pressure? | 2012 | J Dermatolog Treat | pmid:21254889 |